Update on Chronic Fatigue Syndrome Part 1: Clinical Diagnostic Criteria for Chronic Fatigue Syndrome/CFS now called Myalgic Encephalomyelitis or ME/CFS
This ME/CFS CME module is intended to help medical providers identify the core diagnostic criteria of ME/CFS and more confidently make a diagnosis. Each of the diagnostic criteria will be discussed, supported by a brief discussion of the evidence.
Earns: .75 CME credits.
Bateman Horne Center is a 501(c)3 nonprofit clinic and research center.
BHC and Lucinda Bateman MD engage in numerous research protocols but have no specific conflicts of interest related to this presentation.
BHC and Lucinda Bateman MD are conducting a phase I/II clinical trial of an investigational drug for ME/CFS made by Cortene pharmaceuticals. It will not be discussed in this presentation.
BHC and Lucinda Bateman MD are contracted with Lundbeck pharmaceutical as a site for the post label marketing study of a drug for neurogenic orthostatic hypotension. It will not be discussed in this presentation.
All of the relevant financial relationships listed for these individuals have been mitigated.
Planner - Beth Elliott has no relevant financial relationship(s) with ineligible companies to disclose.
Statement of Accreditation:
The Michigan State Medical Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Michigan State Medical Society designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Lucinda Bateman, MD, Founder & Medical Director, Bateman Horne Center
Release Date: January 9, 2019
Renewal Date: January 31, 2022
Expiration Date: January 31, 2025